Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Cibisatamab is a bispecific antibody designed for cancer immunotherapy. It targets CEA (Carcinoembryonic Antigen), which is commonly overexpressed in various solid tumors, including colorectal cancer. Cibisatamab works by engaging T-cells through the CD3, thereby directing the immune response specifically towards CEA-expressing tumor cells
…